Trial · NCT02019719
Results by group467
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 467
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline (CFB) in Hemaglobin (Hgb) at Week 4 | Placebo | -1.52 | Standard Error 0.212 | grams/deciliter (g/dL) | |
| Change From Baseline (CFB) in Hemaglobin (Hgb) at Week 4 | GSK1278863 4 mg | -0.29 | Standard Error 0.200 | grams/deciliter (g/dL) | |
| Change From Baseline (CFB) in Hemaglobin (Hgb) at Week 4 | GSK1278863 6 mg | -0.02 | Standard Error 0.193 | grams/deciliter (g/dL) | |
| Change From Baseline (CFB) in Hemaglobin (Hgb) at Week 4 | GSK1278863 8 mg | 0.60 | Standard Error 0.202 | grams/deciliter (g/dL) | |
| Change From Baseline (CFB) in Hemaglobin (Hgb) at Week 4 | GSK1278863 10 mg | 0.92 | Standard Error 0.196 | grams/deciliter (g/dL) | |
| CFB in Hgb Upto Week 8 | Placebo | CFB at Week 1 | -0.34 | Standard Deviation 0.485 | g/dL |
| CFB in Hgb Upto Week 8 | GSK1278863 4 mg | CFB at Week 1 | -0.23 | Standard Deviation 0.374 | g/dL |
| CFB in Hgb Upto Week 8 | GSK1278863 6 mg | CFB at Week 1 | -0.35 | Standard Deviation 0.462 | g/dL |
| CFB in Hgb Upto Week 8 | GSK1278863 8 mg | CFB at Week 1 | -0.31 | Standard Deviation 0.481 | g/dL |
| CFB in Hgb Upto Week 8 | GSK1278863 10 mg | CFB at Week 1 | -0.17 | Standard Deviation 0.318 | g/dL |
| CFB in Hgb Upto Week 8 | Placebo | CFB at Week 2 | -0.79 | Standard Deviation 0.538 | g/dL |
| CFB in Hgb Upto Week 8 | GSK1278863 4 mg | CFB at Week 2 | -0.32 | Standard Deviation 0.449 | g/dL |
| CFB in Hgb Upto Week 8 | GSK1278863 6 mg | CFB at Week 2 | -0.32 | Standard Deviation 0.780 | g/dL |
| CFB in Hgb Upto Week 8 | GSK1278863 8 mg | CFB at Week 2 | 0.01 | Standard Deviation 0.586 | g/dL |
| CFB in Hgb Upto Week 8 | GSK1278863 10 mg | CFB at Week 2 | 0.24 | Standard Deviation 0.353 | g/dL |
| CFB in Hgb Upto Week 8 | Placebo | CFB at Week 3 | -1.14 | Standard Deviation 0.743 | g/dL |
| CFB in Hgb Upto Week 8 | GSK1278863 4 mg | CFB at Week 3 | -0.42 | Standard Deviation 0.658 | g/dL |
| CFB in Hgb Upto Week 8 | GSK1278863 6 mg | CFB at Week 3 | -0.34 | Standard Deviation 0.776 | g/dL |
| CFB in Hgb Upto Week 8 | GSK1278863 8 mg | CFB at Week 3 | 0.21 | Standard Deviation 0.692 | g/dL |
| CFB in Hgb Upto Week 8 | GSK1278863 10 mg | CFB at Week 3 | 0.37 | Standard Deviation 0.471 | g/dL |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02019719/results